The presence of gastrin and CCK-2/gastrin receptors in human preneoplastic and neoplastic lesions of pancreas and colon suggests a role in cancer development. Gastrin's growth-promoting action has been established, but a role in cellular morphogenetic processes promoting tumor invasion has been elusive. Our aim was (i) to investigate whether activation of the CCK-2R affects cellular morphology, intercellular adhesion and motility, as crucial parameters of epithelial differentiation, and (ii) to identify the signaling pathways and mechanisms implicated. Madin-Darby Canine Kidney (MDCK) cells were chosen to generate an epithelial non-tumorigenic model system expressing human CCK-2R. Epithelial differentiation and motility were analysed upon CCK-2R activation using immunocytochemistry and invasion assays. The functionality of adhesion complexes and activity of signaling proteins was determined with biochemical techniques. CCK-2R activation induced cell dissociation and enhanced invasion, preceded by decreased membrane localization of adherens junction molecules and nuclear accumulation of b-catenin. Concomitantly, and requiring the activation of several signaling pathways, catenins were shifted from the cytoskeletal to the cytoplasmic fraction, suggesting the detachment of the cytoskeleton from the adherens complex. These data represent the first evidence for the CCK-2R, regulating cell -cell and cell -substrate adhesion and support a role for CCK-2R in the progression of carcinoma.
Introduction
The gastrointestinal peptide hormone gastrin is a potent stimulant of gastric acid secretion from the parietal cells of the stomach and an important growth/ differentiation factor for the entire gastrointestinal tract. Besides proliferation, gastrin has been implicated in a number of effects in several cellular systems, such as secretion, stress fiber assembly, anti-apoptosis, hyperglycemia and neoplastic transformation Smith and Watson, 2000b; Taniguchi et al., 1996; Todisco et al., 2001 ). An elaborate biosynthetic pathway results in the release of the major, fully processed, active form, namely amidated gastrin (G17-NH2) from G cells of the gastric antrum (Rehfeld and van Solinge, 1994) . The trophic effects of amidated gastrin are mediated through a G proteincoupled receptor called gastrin/cholecystokinin-2 receptor (CCK-2R, former G/CCK-BR) and have been observed on normal and malignant gastrointestinal tissues Smith and Watson, 2000b) . Several lines of evidence suggest a role for gastrin and CCK-2R in the development of gastrointestinal cancer: (i) up-regulation of gastrin and its receptor, besides non-processed forms, in human colon cancer and pancreatic adenocarcinoma results in endocrine and autocrine (or paracrine) stimulation Schmitz et al., 2001; Smith and Watson, 2000a) , (ii) an epidemiological study determines hypergastrinemia as a factor for development of colorectal cancer (Thorburn et al., 1998) and (iii) gastrin is a target gene of b-catenin-TCF activated pathway in adenomatous poliposis coli disease (APC) . More recent studies with transgenic mice have confirmed the role of this hormone in cell proliferation and gastrointestinal cancer formation (Clerc et al., 2002; Koh and Chen, 2000; Wang et al., 2000) . Gastrin mediated stimulation of the CCK-2R transiently activates a variety of cell type specific transduction pathways, implicated in proliferation, including Phospholipase C, c-src like tyrosine kinases, p125FAK, phosphatidylinositol 3-kinase (PI 3-kinase), and the MAPK, ERK and p38 kinase (Daulhac et al., 1999a,b; Rozengurt and Walsh, 2001) . So far, action of gastrin in digestive cancers has been essentially evaluated with respect to proliferation. Gastrin gene activation in precancerous lesions, causing hyperproliferation, suggests gastrin's action to occur early in the adenoma-carcinoma sequence Smith and Watson, 2000a) . Coinciding with cell growth deregulation, malignant transformation results in the loss of epithelial differentiation, acquirement of mesenchymal characteristics and increasing invasive and metastatic potential. Epithelial-mesenchymal transition (EMT) is therefore a crucial event in the development of cancer and a putative target of cancer therapy (Birchmeier and Behrens, 1994) . Previously, an implication of the CCK-2R in invasiveness of transformed cancer cells has been shown (Hirata et al., 1996; Watson et al., 2000) . However, direct effects of mature, amidated gastrin (G17-NH2) and its receptor in non-transformed epithelial cells on cellcell and cell -substrate adhesion or motility have been elusive. This is of particular importance, considering that pancreatic and colon cancers, in both of which gastrin's implication is supposed, dedifferentiate quickly and are highly invasive and metastatic, rendering the patients survival chance very low. Importantly, dedifferentiation and invasiveness appear after loss of intercellular adhesion, as observed after loss or modulation of the adhesion molecule Ecadherin (Behrens et al., 1989; Nollet et al., 1999) .
In the gastrointestinal tract, epithelial sheets consist of highly polarized cells tightly bound together by characteristic cell junctions at many points of cell -cell and cell -matrix contact. Here, anchoring junctions, which mechanically attach cells and cytoskeleton to neighboring cells, adherens junctions (Steinberg and McNutt, 1999) , or to the extracellular matrix (ECM), focal adhesion sites (Varner and Cheresh, 1996) , are very abundant. Adherens junctions are formed by cadherins, Ca 2+ dependent transmembrane glycoproteins, that mediate homophilic cell adhesion and are connected with the actin network in a complex with intracellular attachment molecules including catenins (a-, b-, g-catenin, p120 CTN ), vinculin and a-actinin (Aberle et al., 1996) . Focal adhesion sites, on the other hand, are formed by glycoproteins secreted by the ECM, such as collagen or proteoglycans and by integrins, the ECM-receptors, which are transmembrane proteins with their cytoplasmic domain complexed with proteins again connecting to actin microfilaments such as talin, a-actinin, vinculin and paxillin (Gumbiner, 1996) . Besides their role in tissue architecture and stability, both types of junctions are further important for other cellular functions including epithelial differentiation, control of cell motility and migration, apoptosis and anchorage dependence of cell proliferation (Varner and Cheresh, 1996) . Intercellular adhesion can be regulated by signals generated locally from the adhesion receptors themselves or by extrinsic signals arising from the classical growth factor receptors. It is thus believed that during malignant development, activation of signaling pathways, possibly those activating proliferation, might result in the modifications of cell -cell and cell -substrate adhesion (Daniel and Reynolds, 1997) .
Here, we have studied the role of the CCK-2R in one aspect of tumor progression, the EMT. Since Madin-Darby Canine Kidney (MDCK) cells are nontransformed, polarized, epithelial cells with all characteristics (cellular junctions) of epithelia in vivo (Behrens et al., 1989; Emami et al., 2001; RosinArbesfeld et al., 2001) , we have analysed the effects of CCK-2R activation on cellular morphology, adhesion and motility in MDCK cells, stably expressing the CCK-2R and responding to gastrin.
Results
The CCK-2R is expressed in the MDCK transfectants MDCK cells were transfected with a cDNA plasmid encoding the human CCK-2R gene. Stable transfectants were expanded and three independent cellular clones (1, 15 and 19) (Seva et al., 1990; C Seva, unpublished) . No specific binding was detected on parental cells. Moreover, the expression of CCK-2R did not alter the epithelial phenotype or the intercellular adhesion of the cells as described below.
Gastrin induces changes in cellular morphology and cellular dissociation
To initially test whether activation of the CCK-2R might be responsible for the loss of epithelial architecture, as observed after malignant transformation, we studied the effects on cellular morphology resulting from different concentrations of gastrin, from 0 nM (Control) to 100 nM, in transfected MDCK cells of the three clones. Control cells (Figure 1b) , grew in colonies of adherent cells as true for parental MDCK cells. However, after 24 h treatment with gastrin, transfected cells dissociated from the colony and several cells had an elongated shape with long membrane extensions, such as lamellipodia ( Figure  1e ,f, arrowheads). This effect was dependent on the concentration of gastrin since almost no effect was observed at 1 nM gastrin (Figure 1d ), whereas decreasing size of colonies and increasing number of isolated, elongated cells were found with increasing concentrations (10 and 100 nM) (Figure 1e,f) . Cells of the three clones showed similar effects upon gastrin treatment, therefore all further experiments shown here were performed with clone 1 and were reproduced with clone 15 (not shown). When gastrin was removed and replaced by fresh medium, the cells became again epithelial forming adhesive colonies, showing that gastrin-mediated cellular effects were reversible ( Figure  1k ). Pretreatment with two selective antagonists of the CCK-2R, L365260 and RPR101048, totally inhibited were grown on plastic culture dishes 24 h in the absence of (b, control) or in presence (a,c,e,f) of different concentrations of gastrin as indicated from 1 -100 nM. Transfected cells had a phenotype similar to parental cells (a) when they were either not treated with gastrin (b), or after pretreatment with 100 nM RPR101048, a selective antagonist of the CCK-2R, which inhibits the cellular effects of gastrin (c). Colony size decrease, cell dissociation and formation of long membrane extensions (e,f, arrowheads) in a dose dependent manner were found in cells treated with increasing concentrations of gastrin (d -f). Bar (a -m) 60 mm. (g -m) Morphological changes induced by gastrin occur in a time dependent manner. Transfected cells (g -m) were grown in the absence (l,m) or in the presence of 10 nM gastrin (g,h,j,k) for the times indicated. First membrane extensions were found after 5 h (h, arrowheads), becoming more frequent together with a reduction in colony size after 15 h (j, arrowheads). Several controls were included, such as the reversibility of the cellular effects, obtained when gastrin was removed and the cells further incubated for 15 h in medium containing 2% FCS (k); the maintained epithelial differentiated phenotype, typical in cells that were treated with EGF 20 ng/ml (l); and the mesenchymal phenotype of cells generating membrane extensions (arrowheads) and dissociating from each other, characteristic for cells that were incubated with anti-E-cadherin antibody (DECMA-1) (100 mg/ml) (m) gastrin mediated effects at 100 nM and 1 mM and partially at 10 nM ( Figure 1c for RPR101048 at 100 nM), thus clearly demonstrating that gastrin exerts its cellular effects through specific activation of the CCK-2R. Moreover, as expected for cells not expressing the CCK-2R, the parental cells displayed the same epithelial phenotype either treated (Figure 1a) or untreated (not shown).
In order to study the time course of the morphological effects, cells were stimulated for different times with gastrin (10 nM). Figure 1g ,h show that first signs became apparent after 5 h, when cells at the border of colonies developed long membrane protrusions and dissociated from the colony (Figure 1h, arrowheads) . After 15 h the frequency of cells with elongated shape and long lamellipodia that had dissociated from the colony, had considerably increased (Figure 1j ). For negative and positive control, cells were respectively treated with 20 ng/ml epidermal growth factor (EGF), known for its particularly weak effect on morphology (Khwaja et al., 1998) , and 100 mg/ml anti-E-cadherin antibody (DECMA-1), known to induce strong EMT, for 24 h (Behrens et al., 1989) . Cells after gastrin treatment ( Figure 1e ,f,j arrowheads) resembled in morphology cells treated with DECMA-1 (Figure 1m , arrowheads), whereas control cells ( Figure 1b) and EGF treated cells (Figure 1l ) were indistinguishable.
CCK-2R activation leads to enhanced motility and invasion in MDCK epithelial cells
An important characteristic behavior of cells that have overcome EMT, besides loss of epithelial morphology, is enhanced motility. To test whether activation of the CCK-2R leads to an increase of random motility, we performed wound-healing assays, where transfected cells were seeded at high density and wounds generated by scratching a cross, removing about 20 cell diameter. After the wound was marked, the cells were stimulated with gastrin. After 18 h, the wound was almost completely healed in the monolayer treated with gastrin ( Figure 2b ) whereas a clear gap remained in the untreated one ( Figure 2a ) suggesting that gastrin induces enhanced motility. To quantify the gastrinstimulated migration, cells were seeded on transwell filters that had been coated with collagen I gels, treated with gastrin and cells that had migrated through the filter, counted. As shown in Figure 2c , cells that had been stimulated with gastrin, clearly displayed enhanced migration in comparison to control cells.
Since gastrointestinal cancers, where gastrin is implicated, are highly invasive and metastatic, we studied whether gastrin, in addition to inducing morphological changes and enhance migration, is further able to increase invasion in vitro. Therefore, transfected cells were seeded into collagen I three-dimensional gels and cultured for further 3 -4 days in medium, either with 10 nM gastrin or without (control), or with anti-Ecadherin antibody (DECMA-1, 100 mg/ml) for positive control. Under these conditions the total cell number was largely similar between parental, untreated and treated cells (not shown). While non-stimulated control cells grew forming compact colonies in collagen I matrix similar to parental MDCK cells, cells stimulated with gastrin and cells treated with anti-E-cadherin antibody grew in a dispersed fashion, often expressed a spindlelike shape and showed invasion throughout the collagen matrix. As shown in Figure 2d stimulation with gastrin leads to an important increase in invasion.
Gastrin induces delocalization of adherens junction molecules preceding cell dissociation
Cells, that have overcome EMT, a characteristic of invasive tumors, display changes in cell -cell, cellsubstrate adhesion and cytoskeleton. We thus next analysed whether the activation of the CCK-2R resulted in altered expression or localization of junctional proteins, thereby affecting functionality of cellular adhesive junctions. Cells were stimulated with gastrin from 0 nM (control) to 100 nM, and processed for semi-quantitative immunofluorescence tests with antibodies against proteins of adherens junctions, focal contacts and the cytoskeleton. Cells were treated with EGF (20 ng/ml) for negative control, or with DECMA-1 (100 mg/ml) for positive control.
DECMA-1 treatment induced cytoplasmic staining of E-cadherin (not shown), p120 CTN , b-catenin and acatenin ( Figure 3a , lower row), in contrast to membrane staining found at cell -cell borders for all adherens junction molecules in parental (not shown), control and EGF-stimulated cells ( Figure 3a , upper and middle rows). Results presented in Figure 3b show that gastrin, similar to DECMA-1, induced delocalization of E-cadherin (not shown), p120 CTN , b-catenin and a-catenin ( Figure 3b , middle and lower rows). While p120 CTN and a-catenin were almost never detected, b-catenin was instead diffusely distributed all over the cytoplasm and in the nucleus of stimulated cells (Figure 3a, b, arrowheads) . These effects were dependent on the concentration of gastrin, being minimal at 1 nM and maximal at 100 nM ( Figure 3b ) and were found in perfect correlation with cellular dissociation.
In order to study the time course of junctional defects, cells were stimulated for different times using gastrin (10 nM) and processed as above. Remarkably, first effects were seen after 1 and 2 h of gastrin treatment long before any morphologic changes had been observed, when both p120 CTN and a-catenin intercellular membrane staining was clearly reduced (Figure 4a, middle and lower rows). Later, after 2 -5 h of treatment, b-catenin staining in addition was found in the nuclei of several cells (Figure 4b, upper row, arrowheads) . Thus, this set of results demonstrate that delocalization of junctional proteins clearly preceded the appearance of intercellular dissociation and remained for the whole 24 h of treatment, while morphological changes in the colonies became evident (Figure 4b ).
To finally see whether cytoskeletal organization and focal adhesion protein localization were similarly affected after gastrin treatment, stimulated cells were stained for F-actin and vinculin. Figure 5 shows that gastrin stimulation resulted in a dramatic decrease of both peripheral and cortical bundles of actin filaments along cell -cell boundaries (Figure 5d , arrowheads) as compared with controls (Figure 5a , arrowheads) and in a projection of stress fibers into cellular membrane protrusions (Figure 5d, arrows) , not found in the controls (Figure 5a, arrows) . Moreover, staining of vinculin in stimulated cells, unlike in control cells, was rather in form of streaks at the end of stress fibers and resembling thick focal contacts (Figure 5e ,f, arrows), while staining at the intercellular membrane, typical for controls, was lost (Figure 5b ,c, arrowheads). So, gastrin definitely induced important changes in several types of cellular junctions and in the actin cytoskeleton, as typical for mesenchymal cells.
Src-, PI 3-kinase and Erk are activated and required for gastrin mediated disruption of adherens junctions and reorganization of actin cytoskeleton Gastrin mediated stimulation of the CCK-2R has been shown to transiently activate a variety of signaling pathways that stimulate proliferation in several cellular models, including Src-kinase, the extracellular regulated kinase (ERK) and the phosphatidylinositol 3-kinase (PI 3-kinase) pathways (Daulhac et al., 1999a,b) . To investigate the roles of Src, PI 3-kinase and ERK1/2 in the mediation of cellular dissociation and cell shape changes triggered by gastrin, transfected cells were pretreated with specific inhibitors of these kinases: (i) PP2 for Src family kinases; (ii) PD098059, a direct inhibitor of MAPKK1/2 thus indirect inhibitor of ERK1/2 activation (Alessi et al., 1995) or (iii) the PI 3-kinase inhibitor LY294002 (Vlahos et al., 1994) and 5 cells were seeded on the upper compartment of Collagen I coated transwell filters, stimulated with 10 nM gastrin and allowed to migrate as described under Materials and methods. Cells, that had migrated, were counted on photographs taken from four different fields (7 mm 2 ) in three independent experiments and averaged. Plotted are the mean and standard error of the mean (6+s.e.m.). (d) Invasion assay into Collagen I gels of control and cells stimulated with gastrin. 3610 3 cells were seeded into Collagen I gels, covered with medium containing 10% FCS only, 10 nM gastrin or 100 mg/ml DECMA1. Invasive cells were distinguished from round, non-invasive cells by their spindle like shape. Invasive versus total cells were counted in four different photomicrograph fields (7 mm 2 ) by focusing up and down in phase contrast. Plotted on the graph are the mean and the standard error of the mean (6+s.e.m.) of the percentage of invasive cells estimated from three independent experiments Loss of adhesion and scattering mediated by the CCK-2R C Bierkamp et al Figure 3 Immunofluorescence for adherens junction proteins in untreated control cells and in cells treated with different concentrations of gastrin. (a) As control, cells were grown for 2 days on cover slips and left untreated (control), fixed and stained as indicated with antibodies for p120 CTN , a-catenin and b-catenin (a, upper row), or treated with EGF 20 ng/ml (a, middle row), which is known to maintain epithelial differentiation, or finally treated with anti-E-cadherin antibody (DECMA-1) (a, lower row), which is known to induce loss of cell adhesion and epithelial-mesenchymal transition. Arrowheads point to nuclear localized b-catenin. (b) Cells were stimulated for 24 h with 1 -100 nM gastrin as indicated and were similarly fixed and stained. In cells treated with gastrin concentrations equivalent or higher than 10 nM cellular dissociation became evident together with a loss of membrane staining of p120 CTN , a-catenin and b-catenin. Note the nuclear accumulation of b-catenin in several cells (middle and lower row, arrowheads). All micrographs were taken with a Sony DXC950 camera. Bar 60 mm Loss of adhesion and scattering mediated by the CCK-2R C Bierkamp et al Figure 4 Immunofluorescence for adherens junction proteins in cells exposed for different times to gastrin. (a,b) Cells were either left untreated (control, upper row) or stimulated with 10 nM gastrin for 1 h (a, middle row), 2 h (a, lower row), 5 h (b, upper row), 18 h (b, middle row) and 24 h (b, lower row) as indicated and were similarly fixed and stained. Already after 1 h of gastrin treatment, clearly before morphological changes were apparent, membrane staining of p120 CTN , a-catenin was strongly reduced (a, middle row) and was almost undetectable from 2 h on (a, lower row) until 24 h of treatment. b-Catenin staining remained membranous initially, but became more diffuse and appeared in several nuclei from 5 h on (b, upper and middle rows, arrowheads). All micrographs were taken with a Sony DXC950 camera. Bar 60 mm subsequently stimulated for 24 h with gastrin (10 nM). Results presented in Figure 6 show that gastrin induced cellular dissociation was completely prevented by each of the three inhibitors since the colonies resembled those of controls consisting of adherent cells (Figure  6a,b) . Concordant with the morphological findings, immunofluorescence labeling revealed membrane localization of p120 CTN and b-catenin at cell -cell contacts, similar to control cells, in cells that had been pretreated with the inhibitors prior to stimulation, (Figure 6a,b) . Consistent with these findings, the actin cytoskeleton was now organized similar to that of control cells, in strong cortical and peripheral bundles as well as short stress fibers in pretreated stimulated cells (Figure 6a ,b arrowheads and arrows, respectively), suggesting that activation of Src-, PI 3-kinase and ERK were required for the cellular effects mediated by gastrin. Because activation of the EGF receptor is necessary for gastrin's mediated cell growth (Miyazaki et al., 1999) , we have additionally analysed the effect of AG1478, an EGF receptor-specific tyrphostin, in our cell model. Pretreatment with AG1478 partially inhibited the morphological effects induced by gastrin, suggesting the EGF receptor as an additional component in the signal transduction pathway (data not shown).
We then verified, whether activation of Src-, PI 3-kinase and ERK resulted from gastrin-mediated activation of the CCK-2R in transfected MDCK cells. We determined kinase activities for p60-Src and PI 3-kinase and detected the active, phosphorylated forms of ERK1/2 on Western blot. As shown in Figure 7 , gastrin treatment induced (i) transient activation of p60-Src with a maximal peak at 30 s after stimulation (Figure 7a ), (ii) prolonged PI-3-Kinase activation with an early activation at 1 min after stimulation that remained elevated for at least 3 h (Figure 7b ) and (iii) both, early, 3 -5 min, and late sustained, 2 -4 h after stimulation, activities of ERK1/2 in MDCK transfected cells (Figure 7c ).
To demonstrate that gastrin mediated activation of signaling cascades leads to biochemical modifications of adherens junction complexes, the detergent solubility of catenins was examined in Western blots and the association between catenins and cadherins analysed by immunoprecipitation experiments with lysats from stimulated and control cells. Indeed, when adherens junctions are functional, catenins, providing a link between cadherin complexes and the actin cytoskeleton, are highly concentrated in the cytoskeletal, detergent-insoluble fraction after cellular lysis. As Figure 5 Double immunofluorescence for F-actin (green) and vinculin (red) analysed by confocal laser scanning microscopy. Cells were either left untreated (a -c) or treated with 10 nM gastrin (d -f) fixed and stained using alexa488-phalloidin and anti-vinculin antibody. Actin filaments in the control cells were organized in cortical and peripheral bundles 5 (a, arrowheads) and stress fibers (a, arrows). At cell -cell borders, vinculin colocalized with actin filaments in yellow lines (b,c, arrowheads). After gastrin treatment the actin cytoskeleton was strongly reorganized, peripheral and cortical bundles had almost disappeared (d, arrowheads) and stress fibers projected in to membrane extensions (d, arrows). Here vinculin was localized in streaks at the end of actin fibers (e,f, arrows), while membrane staining at cell -cell borders had disappeared. Confocal images are a superposition of five optical sections. Bar (af) 20 mm Loss of adhesion and scattering mediated by the CCK-2R C Bierkamp et al shown in Figure 8a , b-catenin, a-catenin, p120
CTN and E-cadherin (not shown) were detected at moderate levels in the soluble (lane 1) and at high levels in the insoluble cytoskeletal fraction (lane 6) of control cells. Remarkably, after gastrin treatment, b-catenin, Ecadherin (not shown) but particularly a-catenin and p120 CTN were found at increased levels in the soluble (lane 2) and, concordant with the immunofluorescence stainings, at reduced levels in the insoluble fraction (lane 7), consistent with the idea that cadherin-catenin complexes are no longer associated to the actin cytoskeleton after gastrin treatment. Pretreatment of the cells with the kinase inhibitors PP2 (lanes 3 and 8), PD098059 (lanes 4 and 9) and LY294002 (lanes 5 and 10) prior to gastrin (10 nM) treatment prevented the shift of all three catenins and E-cadherin (not shown) from the insoluble pool to the soluble pool, resulting in the distribution similar to that of the control lysats (lanes 1 and 6). To further investigate whether gastrin stimulation would additionally affect the direct associa- tion between E-cadherin and catenins, immunoprecipitation experiments were performed with stimulated and control cell lysats, using antibodies against p120 CTN and b-catenin. Concordant with our previous results, slightly decreased levels of E-cadherin were coprecipitated with either p120 CTN or b-catenin in the lysats of gastrin treated cells (Figure 8b ).
Discussion

Role of CCK-2R in the regulation of cellular morphology
The present study provides evidence for a new biological role of a G protein-coupled receptor, in particular the CCK-2R, in the modification of morphological cellular processes including cellular adhesion, motility and invasion in non-tumorigenic epithelial cells. While ligand mediated activation of the CCK-2R in several cellular systems results in a number of effects, such as section, stress fiber assembly, increased proliferation, anti-apoptosis and hyperglycemia, no effects on cellular morphology and cell adhesion have yet been described in non-tumorigenic cells to our knowledge Smith and Watson, 2000b; Taniguchi et al., 1996; Todisco et al., 2001) . Our results differ from those of a recent report comparing biological activities of differentially processed forms of gastrin on a gastric epithelial cell line. Here, treatment with an incompletely processed non-amidated form, glycine-extended gastrin (G-Gly), Figure 7 (a) Early kinetic of the activity of p60-Src induced by gastrin treatment. P60-Src was immunoprecipitated from cell lysates of gastrin-treated cells after the time indicated. Kinase reaction was performed in vitro using enolase as a substrate. (b) Early and prolonged activation kinetics of PI 3-kinase induced after gastrin treatment. PI 3-kinase was immunoprecipitated from cell lysates of gastrin-treated cells after the time indicated. Kinase reaction was performed in vitro using phosphatidyl inositol as a substrate. When indicated, cells were pretreated for 1 h with the PI 3-kinase inhibitor LY294002 (20 mM) before gastrin addition. (c) Early and prolonged activation kinetics of ERKs after gastrin treatment. The phosphorylation of ERK1/2 was determined by immunoblot containing equal amounts of proteins (50 mg) of cell lysats from stimulated and control cells and probed with an antibody directed against the phosphorylated form of ERK (phospho-ERK). The bottom panels show control blots probed with an anti-ERK2 antibody (total ERK2) Loss of adhesion and scattering mediated by the CCK-2R C Bierkamp et al which acts through a distinct receptor, was found to induce transient cell dissociation during wound-healing assays, while amidated gastrin only induced proliferation (Hollande et al., 2001) . Differences residing in the specific properties of each cellular model, activating a variety of a cell type specific signaling cascades upon CCK-2R signaling, may explain these discrepancies. Indeed, our findings of early and late activation of ERK-and PI 3-kinase pathways after gastrin treatment contrast with Hollande's results showing only short term activation of ERK and lack of activation of the PI 3-kinase dependent pathway Akt/PKB after gastrin treatment. Since the receptor for G-Gly has not yet been cloned, we have not been able to compare the effects of gastrin with G-Gly in the MDCK cell model system. Interestingly, we do have additional evidence that stimulation of the CCK-2R in other cell lines, that either endogenously (human embryonic kidney cells) or stably (Chinese hamster ovary cells and NIH3T3 cells) express the CCK-2R, besides stimulating proliferation, again affects cell morphology and migration (C Bierkamp, in preparation).
Importantly, there is additional evidence from the use of antiserum and antagonists blocking invasion of human colon and pancreatic cancer cells that favor the idea of the CCK-2R being implicated in invasiveness in vivo (Hirata et al., 1996; Watson et al., 2000) . Most of the epithelial cell lines expressing the CCK-2R are neoplastic colorectal or pancreatic cell lines that have several pathways activated (Ki-Ras, b-catenin, APC, EGF receptor, loss of E-cadherin) resulting in cross talk between signal transduction pathways and cell transformation. Moreover, they often have up-regulated expression of one or other gastrin binding receptors (CCK-1R, G-Gly receptor, CCK-CR) or additional splice variants (CCK-BR4isv) rendering it complicate to sort out specific signals after CCK-2R activation. We have chosen the MDCK cellular model system for several reasons: because (i) it represents a non-transformed and non-tumorigenic cellular system with all characteristics of epithelia in vivo (Behrens et al., 1989) ; (ii) it exclusively expresses the CCK-2R after transfection; (iii) it has been widely selected to study the role of intestinal/colonic proteins in cell biological processes (Emami et al., 2001; Rosin-Arbesfeld et al., 2001) ; and (iv) it has been the subject of extensive studies concerning EMT enabling the comparison between different factors inducing EMT (Khwaja et al., 1998) . Thus, MDCK cells expressing the CCK-2R, allowed us to directly study a possible role of the CCK-2R in one aspect of cancer progression, EMT. Our results show that, upon CCK-2R activation, transfected MDCK cells display changes typical of an EMT and reflect a state of dedifferentiation and malignancy induced in epithelial cells. Therefore, our results strongly support a role of CCK-2R in the development of cancer in the adenomacarcinoma sequence in vivo. Systematic activation of the CCK-2R was a prerequisite for our experiments. The concentrations, where amidated gastrin exerted cellular effects were in good agreement with those locally found in the pathological tissues (Rehfeld and van Solinge, 1994) . In the normal situation in vivo, prolonged activation of the CCK-2R is not expected because of (i) the restricted expression of the CCK-2R and of (ii) the transient and restricted release of gastrin with a short half-life and a physiological serum concentration of gastrin around 25 pM in the fasting state (Rehfeld and van Solinge, 1994) . However, in the pathological situation, up-regulation of gastrin and the CCK-2R, besides non-processed forms, may result in autocrine secretion and self-stimulation besides endocrine stimulation. This could lead to growth advantage for transformed cells and neoplastic progression. Such a view is supported by a recent work describing that in the APC disease mouse model APC (Min+), the gastrin gene is a target gene of the APC/b-catenin/TCF activated pathway that stimulates proliferation and neoplastic progression Watson and Smith, 2001) . In good agreement with this report are the facts that, both gastrin and CCK-2R are often upregulated in human carcinomas and precancerous lesions of the gastrointestinal tract and that in an epidemiological study increased colorectal cancer risk has been attributed to prolonged hypergastrinemia (Smith and Watson, 2000a,b; Thorburn et al., 1998) . Interestingly, a novel splice variant of the CCK-2R has recently been identified, which has constitutive activity and is exclusively expressed in colon and pancreatic cancers, suggesting a role in cancer formation (Ding et al., 2002; Hellmich et al., 2000) . We have further evidence from a genetically engineered mutant of the CCK-2R (CCK-2Rconst) with constitutive activity, that the CCK-2R can stimulate proliferation, motility and oncogenic characteristics in fibroblasts (data not shown). Additionally, prolonged activation of the CCK-2R has been mimicked in two different transgenic mice models, due to either (i) constitutive expression of gastrin in the gastrointestinal tract or (ii) ectopic expression of the CCK-2R itself, and has again been shown to cause gastric and pancreatic cancer respectively (Clerc et al., 2002) . However, our work does not exclude the possible additional role of non-processed forms of gastrin in cancer progression .
Our study further demonstrated that alterations in adherens junctions precede the morphologic effects and further require gastrin-mediated activation of signaling cascades including Src, PI 3-kinase and ERK1/2. Although gastrin acts through a G protein-coupled receptor, there are several similarities with signaling pathways activated by HGF/SF through its tyrosine kinase receptor, c-met, in MDCK cells (Weidner et al., 1993) . Both factors result in the activation of p60-Src, p125FAK (our unpublished data), both early and prolonged PI 3-kinase and ERK activation (Chen et al., 1998; Khwaja et al., 1998; Potempa and Ridley, 1998) . P60-Src and p125FAK are cytoplasmic kinases, located to junctions and known to both modify junctional complexes and to transduce oncogenic and migratory signals (Behrens et al., 1993; Owens et al., 2000) . Both kinases do act upstream of the MAPK pathway (Chen et al., 1998) and, upon gastrin treatment, upstream of PI 3-kinase (Daulhac et al., 1999a) . It has been shown, that rapid ERK and PI 3-kinase activation are induced upon action of many growth factors such as EGF and stimulate cell proliferation. Interestingly, prolonged activation of both ERK and PI 3-kinase, as shown here for the first time after gastrin treatment, are required for the scattering response of MDCK cells (Khwaja et al., 1998; Potempa and Ridley, 1998) .
Mechanisms responsible for gastrin mediated morphological changes
Our results demonstrate that CCK-2R activation strongly impairs E-cadherin mediated adhesion as characteristic of cells after malignant transformation. Two aspects are noteworthy: (i) The reduced association between E-cadherin, p120
CTN and b-catenin found after gastrin treatment, eventually due to a mechanism activated by gastrin, such as modification of Ecadherin or catenins resulting in a reduced complex formation. (ii) More importantly, the clear shift of the catenins from the insoluble (cytoskeletal) to the soluble pool upon gastrin treatment, suggesting a mechanism that results in the detachment of the actin cytoskeleton from the cadherin complex. Biochemical analysis indicates that the reduction of catenins in the insoluble Loss of adhesion and scattering mediated by the CCK-2R C Bierkamp et al pool is not the result of a reduced protein expression, as we can still detect them in the soluble pool. Notably, both p120
CTN and a-catenin are most strongly shifted from the insoluble to the soluble fraction and are almost not detectable at the membrane by immunofluorescence. Several hypotheses could explain the destabilization of the adhesion complex: (i) Binding of p120
CTN to E-cadherin is believed to induce Ecadherin clustering that confers particularly strong cell -cell adhesion between epithelial cells . Therefore, redistribution and reduction of p120 CTN in the E-cadherin-complex as induced by gastrin would lead to reduction of cell adhesion. (ii) Cytoplasmic p120 CTN has been shown to modulate the activity of the small G-proteins, RhoA and Rac1, regulating stress fiber assembly, cell adhesion and motility Grosheva et al., 2001; Noren et al., 2000) . Changes on the expression and localization of p120 CTN have been described in many gastrointestinal cancers and a role in cancer progression been proposed (Jawhari et al., 1999; Skoudy et al., 1996) . (iii) Since a-catenin is the crucial link between the cadherin -catenin complex and the actin cytoskeleton, cell adhesion is abolished, if acatenin is not present in the complex (Torres et al., 1997) . a-Catenin thus plays the role of a tumor suppressor protein besides E-cadherin and b-catenin in many types of cancers (Nollet et al., 1999) . Since acatenin is normally not modified, we speculate that the E-cadherin-b-catenin complex is modified so that acatenin is prevented from binding; in particular, since E-cadherin association with b-catenin is, even though reduced, still detectable after gastrin treatment. Moreover our results do show a requirement of Src, ERK and PI 3-kinase activity. Gastrin might induce modifications such as tyrosine phosphorylation of the E-cadherin -catenin complex, particularly in light of p120 CTN and b-catenin being substrates of Src, or ser/ thr phosphorylation of the E-cadherin-catenin complex but also phosphorylation of cytoskeleton-associated proteins. This might either influence the integrity of the E-cadherin complex or alternatively, destabilize the interaction of the cadherin complex with the cytoskeleton (Ozawa and Kemler, 1998) . Future studies will be required to unravel the posttranslational modifications of the E-cadherin-catenin complex, induced upon gastrin signaling, that may be responsible for cellular dissociation.
Finally, it has recently been found that b-catenin can form a complex with p85 alpha and p110 alpha subunits of PI 3-kinase which is metabolically stable (Espada et al., 1999) . Cytoplasmic, stable b-catenin is known to enter the nucleus, to form a complex with TCF/Lef transcription factors and to activate gene transcription promoting neoplastic progression (BenZe'ev et al., 2000) . Among the target genes, genes coding for the metalloproteinase Matrylisin or the ECM component fibronectin as well as cyclin D and gastrin have been identified (Ben-Ze'ev et al., 2000; . Thus, nuclear accumulation of bcatenin found after CCK-2R activation, could induce the expression of matrylisin and fibronectin and cause autocrine expression of gastrin and promote neoplastic progression.
In conclusion, we have shown here a novel biological role for the CCK-2R in the modulation of cellular processes such as morphology, adhesion and motility and propose an implication in EMT during neoplastic progression. This is of consequence for the evaluation of the CCK-2R in cell biological, cancer and therapeutical research.
Materials and methods
Cell culture
MDCK cells (a gift from H Paris) were stably transfected, using Fugene 6 (Roche) with a plasmid (PRFEneo) encoding the human CCK-2R, previously used to generate transgenic mice expressing functional human CCK-2R (Saillan-Barreau et al., 1998). The cells were cultured in aMEM containing 10% FCS and G418 at 500 mg/ml (Gibco BRL) at 378C and in a 95% air, 5% CO 2 atmosphere.
Binding experiments
Binding experiments were performed as described previously (Seva et al., 1990) . Briefly, 1.25610 5 cells seeded into 24-well plates were incubated with 50 pM of 125 I-BH-(Thr, Nle-CCK1-9s) with or without excess of unlabeled gastrin. Non specific binding, determined in presence of 1 mM gastrin (human gastrin 2 -17ns ), purchased from Bachem, (Switzerland), was less than 10% of total binding.
Wound healing assay
Cells were seeded at high density (10 5 ) on plastic 6-wells, grown for 24 h, deprived for further 24 h in medium containing 2% FCS. A cross was scratched, removing approximately 20 cell diameters, marked and the cells further stimulated with 10 nM gastrin. Phase contrast micrographs were taken after 18 h of stimulation. One experiment out of three is shown.
Cell migration assay
10
5 cells were seeded on the upper compartment of Collagen I (Sigma; 100 mg/ml) coated and polymerized 6-well transwell filters (8 mm pores, Nunc-Nalgene) in medium containing 10% FCS. After 1 h, 10 nM gastrin was added into the lower compartment and the cells allowed to migrate for 48 h in the incubator. Cells that remained on the upper side of the filter were removed with a cotton swab, and cells that had migrated through the filter were fixed in methanol and stained with crystal violet. Cells that had migrated were counted on photographs taken from four different fields (7 mm 2 ) in three independent experiments and averaged.
Invasion assay photomicrograph fields (7 mm 2 ) were analysed by focusing up and down in phase contrast using an inverted microscope (Nikon). Non-invasive and invasive cells, identified by their spindle-like shape (Behrens et al., 1989) , were counted per field. The percentage of invasive cells was estimated from the number of invasive cells over the total number of cells. The average from three independent experiments was determined.
Immunofluorescence and morphological analysis 3610 4 cells were seeded on 6-well plates containing cover slides. After 24 h, the medium was exchanged for medium containing 2% FCS (starvation). After 18 h, 0 -10 nM gastrin, or 20 ng/ml human EGF (Sigma), or 100 mg/ml DECMA-1 was added to the medium and the cells were incubated for additional 24 h. Where noted, cells were pretreated for 30 min prior to Gastrin stimulation with the CCK-2R antagonists RPR101048 (Rhone-Poulenc-Rorer) and L365260 (Sanofi); both 10 nM -1 mM, or for 1 h with the following inhibitors (Calbiochem): LY294002, 20 mM; PD98059, 30 mM; PP2, 30 mM. After 24 h cell morphology was photographed using an inverted phase contrast microscope (Nikon) and the cells subsequently fixed in 2% paraformaldehyde, permeabilized with 0.2% Triton X-100, blocked in 2% BSA and further incubated with primary and secondary antibodies according to standard immunofluorescence methods. The following antibodies were used: anti Ecadherin, DECMA-1 (gift from Dr R Kemler), anti-bcatenin (C19220, Signal Transduction Laboratories), anti p120 CTN (clone15D2, a gift from Dr A Reynolds), anti-acatenin (C2081, Sigma), anti-vinculin (V9131, Sigma). Alexa Fluor 488 TM Phalloidin (A-12379, Molecular Probes) was used to stain F-actin. Secondary antibodies coupled to CY-3 or FITC were purchased from Sigma and Jackson Immunoresearch Laboratories. Slides were mounted in PBS/Glycerol or Mowiol (Calbiochem) and analysed on a Nikon E400 microscope with a Sony DXC 950 camera and Visiolab 2000 software or on a confocal laser-scanning microscope Leica TCS-SP2 using LCS-software. Images were further assembled using Adobe Photoshop software. For semi-quantitative comparisons, identical volumes of antibody mix were used for all samples and identical exposure times taken.
Kinase assays
Src or PI 3-kinase activities were carried out on cell lysates immunoprecipitated with respectively anti-p60-Src (Oncogene Science), or anti-p85 antibodies (a gift from Drs Le Marchand-Brustel and JF Tanti, Nice, France), as previously described (Daulhac et al., 1999a) . One experiment out of three is shown.
Western blotting
Whole cell lysates or immunoprecipitated proteins (10 6 cells cultured in 9 mm culture dishes similarly as for immunofluorescence tests) were prepared as described previously (Hinck et al., 1994) , separated by SDS -PAGE and transferred onto PVDF membranes. The membranes were further immunoblotted with the indicated antibodies as described previously (Kowalski-Chauvel et al., 1996) . Proteins were visualized using 125 I-Protein A or enhanced chemiluminescence reagent (phospho-ERK detection). The following antibodies were used, anti-b-catenin (Signal Transduction), anti-p120 CTN , (clone15D2, a gift from Dr A Reynolds), anti-a-catenin (C2081, Sigma), anti-E-cadherin, anti-phospho-ERK (New England Biolabs), anti-ERK2 (Santa Cruz). One experiment out of three is shown.
